Global Developmental Delay
13
2
2
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (13)
Repetitive Transcranial Magnetic Stimulation Combined With Language Training for Language Disorders in Children With Global Developmental Delay
Register for Patients With Thyroid Hormone Resistance.
Virtual Reality and Neuropsychiatric Rehabilitation in Patients With Global Developmental Delay.
Intensive Therapy for Children With Microcephaly, Hyperkinetic Movements, or Global Developmental Delay
Workshops for Children With Global Developmental Delays
The Indonesian Version of Ages and Stages Questionnaire III Accuracy Compared to Bayley Scales of Infant Development III
Validity and Reliability of Indonesian Translated Ages and Stages Questionnaires - Third Edition (ASQ-3) as a Screening Tool for Developmental Delay in 1-12 Months Old Children
Reliability and Validity of CCISO for Diagnosis of Autism Spectrum Disorder
The Early Integrated Intervention for Child Brain-developmental Disorders in China
Predicting Developmental Disability Type and Mental Retardation Level in Children With General Developmental Delay
Umbilical Cord Blood Therapy for Global Developmental Delay
Animal Assisted Therapy in a Pediatric Setting
Umbilical Cord Blood Therapy for Children With Global Developmental Delay